World
Regulatory Review of Wellness Peptides
A panel will meet to advise the FDA on whether specialized pharmacies should be allowed to produce certain popular wellness peptides. The decision could impact consumer access and industry practices.
Coverage timeline — 1 article
NPR
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
2026-07-22 09:00 UTC